Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MR-HIFU for Painful Bone Metastases
NCT02718404Terminated
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"
- Start
- Sep 2015
- Primary completion
- Jul 2018
- Countries
- 1
01
Overview
Open-label, single-arm trial in bone metastasis, sponsored by Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori". Primary endpoint: Pain response at 90 days. Started Sep 2015; status: terminated.
02
Conditions
bone metastasis
Beyond the preview
Go deeper on NCT02718404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02718404.